A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear)

NCT03647475 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

752

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

COMBINATION_PRODUCT: Device: Medtronic Resolute Onyx Zotarolimus-Eluting Coronary Stent System Treatment Followed by one-month DAPT

Sponsor

Medtronic Vascular